Biocon in its Environmental, Social and Governance (ESG) scores as assessed by S&P Global’s Corporate Sustainability Assessment (CSA) for 2024 has achieved an improvement to 69 in 2024, up 6 points ...
Novo Nordisk announces positive results from phase 1b/2a trial with subcutaneous amycretin in people with overweight or obesity: Bagsværd, Denmark Monday, January 27, 2025, 13:00 ...
Moderna awarded tender for the supply of Its mRNA Covid-19 vaccine in European Union: Cambridge, Massachusetts Monday, January 27, 2025, 12:00 Hrs [IST] Moderna, Inc. announced th ...
EMA validates X4 Pharma’s marketing authorization application for mavorixafor to treat WHIM syndrome: Boston Monday, January 27, 2025, 11:00 Hrs [IST] X4 Pharmaceuticals, a comp ...
Merck expands operations to position itself as a critical manufacturing hub in the APAC region: Our Bureau, Bengaluru Monday, January 27, 2025, 10:45 Hrs [IST] Merck has announced ...
NUS researchers pioneer DNA-tagged gold nanoparticles for targeted cancer treatment: Singapore Monday, January 27, 2025, 09:00 Hrs [IST] A team of researchers from National Univer ...
Nandita Vijayasimha, Bengaluru Monday, January 27, 2025, 08:00 Hrs [IST] ...
Indian healthcare providers caution on risk of Mtb spread as US FDA issues guidance to reduce risk of transmission: Nandita Vijayasimha, Bengaluru Monday, January 27, 2025, 08:00 ...
Parliamentary panel asks NPPA to set up PMRUs in remaining states and UTs: Gireesh Babu, New Delhi Monday, January 27, 2025, 08:00 Hrs [IST] The Parliamentary Standing Committee o ...
With an aim to make Odisha a pharmaceutical powerhouse in the eastern part of the country, the government of Odisha is preparing an exclusive pharma policy 2025 for the state. Prior to the release of ...
Exports of drugs and pharmaceuticals during the month of December, 2024 registered less than one per cent growth, a decline compared to the growth reported in the previous months. The growth of ...
Rakuten Medical initiates global phase 3 trial of ASP-1929 photoimmunotherapy in combo with pembrolizumab to treat recurrent head and neck cancer: United States Saturday, January ...